Kim Dong Hyun, Kim Jaeyoung, Jeong Hyun Jeong, Lee Hyun Ju, Kim Mee Kum, Wee Won Ryang
Department of Ophthalmology, Gachon University Gil Medical Center, Incheon, Korea.
Laboratory of Corneal Regenerative Medicine and Ocular Immunology, Seoul Artificial Eye Center, Seoul National University Hospital Biomedical Research Institute, Seoul, Korea.
Xenotransplantation. 2016 May;23(3):202-10. doi: 10.1111/xen.12234. Epub 2016 May 11.
Xenocorneal transplantation is one of the solutions for shortage of donor cornea, and remarkable advances have been made in pig-to-rhesus studies from the immunological perspective. Most successful preclinical trials have been carried out with corneas of the Seoul National University (SNU) miniature pig (SNU pig, genetically unmodified) as donor tissues; however, there has been no biophysico-functional evaluation of the SNU pig cornea as a substitute for human cornea. The purpose of this study was to investigate the biophysical and functional compatibility of SNU pig cornea for use in human clinical trials.
Ninety-three eyeballs obtained from 51 SNU pigs were used to evaluate the physical properties and changes in porcine corneal endothelial cells (PCECs) depending on preservation time and storage condition before surgery, proliferative and functional characteristics of PCECs, and the microbiologic safety of porcine cornea. Corneal diameters and curvatures, axial length, anterior chamber depth, and central corneal thickness were measured and compared with previously reported human data. Corneal endothelial cell density (ECD) was serially measured with a confocal microscope during 7 days of preservation in the same storage solution used for human corneas. Corneal endothelial cell proliferation and immunofluorescence staining of Na- and K-dependent ATPase in PCECs were evaluated after 7 days of preservation. The corneoscleral rims of SNU pigs were cultured for gram-positive bacteria, gram-negative bacteria, and fungi to evaluate their microbiological safety.
Corneal diameter and thickness in SNU pigs was larger than human and corneal curvature was flatter; however, they were within surgically operable ranges. Mean ECD (day 0) and ECD loss after 7 days of preservation were 2625 ± 81 cells/mm(2) and 7.60 ± 1.53%, respectively, which is comparable to human ECD and ECD loss in the same conditions. The ECD of SNU pigs was inversely decreased with aging (R(2) = 0.4034, P = 0.001), and the estimated ages of pigs whose mean ECD would be more than 2500 and 2200 cells/mm(2) or more were 48 and 72 months or less, respectively. Mean doubling time of the endothelial cells was 52 to 96 h depending on the method used. The Na- and K-dependent ATPase pump in SNU pig cornea was well maintained for 7 days. No cultured microorganisms were found upon using the modified European Eye Bank Association protocol, which included additional antiseptic management during the enucleation procedure.
In conclusion, SNU pig cornea is feasible for xenocorneal transplantation using the same preservation protocol as human with respect to biophysical and functional properties and can be stored for up to 7 days for transplantation in human clinical trials. An age limitation of donor pigs may be required for qualified corneal products to be used in human trials.
异种角膜移植是解决供体角膜短缺的方法之一,从免疫学角度来看,猪到恒河猴的研究已经取得了显著进展。大多数成功的临床前试验都是以首尔国立大学(SNU)小型猪(SNU猪,基因未修饰)的角膜作为供体组织进行的;然而,尚未对SNU猪角膜作为人类角膜替代品进行生物物理功能评估。本研究的目的是调查SNU猪角膜在人类临床试验中的生物物理和功能兼容性。
使用从51只SNU猪获得的93只眼球来评估猪角膜内皮细胞(PCECs)的物理特性以及术前保存时间和储存条件对其的影响、PCECs的增殖和功能特性以及猪角膜的微生物安全性。测量角膜直径和曲率、眼轴长度、前房深度和中央角膜厚度,并与先前报道的人类数据进行比较。在与人类角膜相同的储存溶液中保存7天期间,用共聚焦显微镜连续测量角膜内皮细胞密度(ECD)。保存7天后,评估PCECs中内皮细胞的增殖情况以及钠钾依赖ATP酶的免疫荧光染色。培养SNU猪的角膜缘组织以检测革兰氏阳性菌、革兰氏阴性菌和真菌,以评估其微生物安全性。
SNU猪的角膜直径和厚度大于人类,角膜曲率较平坦;然而,它们都在手术可操作范围内。平均ECD(第0天)和保存7天后的ECD损失分别为2625±81个细胞/mm²和7.60±1.53%,这与相同条件下人类的ECD和ECD损失相当。SNU猪的ECD随年龄增长呈反比下降(R² = 0.4034,P = 0.001),平均ECD分别超过2500和2200个细胞/mm²时,猪的估计年龄分别为48个月和72个月及以下。根据所使用的方法,内皮细胞的平均倍增时间为52至96小时。SNU猪角膜中的钠钾依赖ATP酶泵在7天内保持良好。使用改良的欧洲眼库协会方案(包括在眼球摘除过程中增加防腐处理)未发现培养出的微生物。
总之,就生物物理和功能特性而言,SNU猪角膜使用与人类相同 的保存方案进行异种角膜移植是可行的,并且可以储存长达7天用于人类临床试验移植。为了使合格的角膜产品用于人类试验,可能需要对供体猪设定年龄限制。